187 related articles for article (PubMed ID: 26525523)
21. Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure.
Lindenfeld J; Gupta R; Grazette L; Ruddy JM; Tsao L; Galle E; Rogers T; Sears S; Zannad F
JACC Heart Fail; 2021 Jun; 9(6):430-438. PubMed ID: 33992562
[TBL] [Abstract][Full Text] [Related]
22. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
Mann JA; Abraham WT
Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
[TBL] [Abstract][Full Text] [Related]
23. Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy.
Gronda E; Brambilla G; Lovett EG; Costantino G; Georgakpoulos D; Vanoli E
J Cardiol Cases; 2014 Jul; 10(1):4-6. PubMed ID: 30534210
[TBL] [Abstract][Full Text] [Related]
24. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.
Georgakopoulos D; Little WC; Abraham WT; Weaver FA; Zile MR
J Card Fail; 2011 Feb; 17(2):167-78. PubMed ID: 21300307
[TBL] [Abstract][Full Text] [Related]
25. Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy.
Nottebohm PI; Dumitrescu D; Hamacher S; Hohmann C; Madershahian N; Baldus S; Reuter H; Halbach M
Ther Adv Cardiovasc Dis; 2022; 16():17539447221131203. PubMed ID: 36305639
[TBL] [Abstract][Full Text] [Related]
26. [Cardiac contractility modulation. A new form of therapy for patients with heart failure and narrow QRS complex?].
Kleemann T
Herz; 2015 Nov; 40(7):945-51. PubMed ID: 26446549
[TBL] [Abstract][Full Text] [Related]
27. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
Wallbach M; Koziolek MJ; Wachter R
Internist (Berl); 2018 Oct; 59(10):1011-1020. PubMed ID: 30182192
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review.
Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC
ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746
[TBL] [Abstract][Full Text] [Related]
29. Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.
Grassi G; Brambilla G; Pizzalla DP; Seravalle G
Curr Hypertens Rep; 2016 Aug; 18(8):60. PubMed ID: 27334011
[TBL] [Abstract][Full Text] [Related]
30. Carotid Sinus/Nerve Stimulation for Treatment of Resistant Hypertension and Heart Failure.
Yin D; Slavin KV
Prog Neurol Surg; 2015; 29():83-93. PubMed ID: 26394178
[TBL] [Abstract][Full Text] [Related]
31. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of baroreflex activation therapy for heart failure: A meta-analysis of randomized controlled trials.
Cai G; Guo K; Zhang D; Qin S
Medicine (Baltimore); 2020 Nov; 99(45):e22951. PubMed ID: 33157936
[TBL] [Abstract][Full Text] [Related]
33. Non-pharmacological modulation of the autonomic tone to treat heart failure.
Singh JP; Kandala J; Camm AJ
Eur Heart J; 2014 Jan; 35(2):77-85. PubMed ID: 24174128
[TBL] [Abstract][Full Text] [Related]
34. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients.
Auricchio A; Delnoy PP; Regoli F; Seifert M; Markou T; Butter C;
Europace; 2013 Aug; 15(8):1191-7. PubMed ID: 23703364
[TBL] [Abstract][Full Text] [Related]
35. [New Technologies and Devices of Heart Failure with Reduced Ejection Fraction].
Fan X; He Q; Feng S; Wang J
Zhongguo Yi Liao Qi Xie Za Zhi; 2023 Feb; 47(2):185-189. PubMed ID: 37096473
[TBL] [Abstract][Full Text] [Related]
36. First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.
Zile MR; Abraham WT; Lindenfeld J; Weaver FA; Zannad F; Graves T; Rogers T; Galle EG
Am Heart J; 2018 Oct; 204():139-150. PubMed ID: 30118942
[TBL] [Abstract][Full Text] [Related]
37. Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure.
Doumas M; Faselis C; Kokkinos P; Anyfanti P; Tsioufis C; Papademetriou V
Curr Vasc Pharmacol; 2014 Jan; 12(1):30-7. PubMed ID: 23905599
[TBL] [Abstract][Full Text] [Related]
38. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
39. Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.
Gronda E; Francis D; Zannad F; Hamm C; Brugada J; Vanoli E
J Cardiovasc Med (Hagerstown); 2017 Sep; 18(9):641-649. PubMed ID: 28737621
[TBL] [Abstract][Full Text] [Related]
40. Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
Gronda E; Vanoli E
Curr Heart Fail Rep; 2016 Dec; 13(6):273-280. PubMed ID: 27854009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
